We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
-13.37%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$654M
AUM Growth
-$479M
(-42%)
Cap. Flow
-$300M
Cap. Flow
% of AUM
-45.83%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2016 Portfolio in Review
As of Q1 2016, Crestline Management held 1 position worth $654M, down 42% from $1.13B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Crestline Management withdrew a net $300M in Q1 2016, reducing 1 holding. Its largest reduction was Juno Therapeutics, Inc., cutting an estimated $300M.
- Crestline Management's biggest Q1 2016 reduction was Juno Therapeutics, Inc., cutting an estimated $300M.
- Crestline Management's ten largest holdings make up 100% of its $654M portfolio in Q1 2016.
- Crestline Management opened 0 new positions and closed 0 in Q1 2016.
- Crestline Management's portfolio value fell 42% quarter-over-quarter to $654M.
Based on Crestline Management's 13F filing for Q1 2016, filed 13 May 2016.